[ad_1]
The decision by several European countries to ban the application of the coronavirus vaccine from pharmaceutical company AstraZeneca and the University of Oxford as a precautionary measure has caused global unrest: the immunizer is one of the favorites for its low price – around $ 3 and its practicality since it can be stored between 2 and 8 ° C, the temperature at which a refrigerator cools.
Austria was one of the first countries in the regional bloc to withdraw from circulation a batch of vaccine associated with the death of an immunized by “Severe bleeding disorder” which had generated thrombosis in the woman. At that time, the health authorities had clarified that there was no cause and effect relationship between what had happened and the inoculant. Two weeks after this case, reports of possible adverse reactions associated with the AstraZeneca vaccine have already been audited by regional and international health regulators.
// What the scientific evidence says about the safety of AstraZeneca vaccines
As the days go by, more and more data is added to the investigation which attempts to clarify the deaths that triggered the bans. A report from researchers at Vienna General Hospital found that an “extremely rare” immune reaction caused the thrombosis which resulted in the death of an Austrian nurse after being inoculated with the AstraZeneca vaccine.
Speaking to Austrian television station ORF, a spokesperson for this hospital, who participated in the autopsy of the deceased woman, confirmed the report’s conclusion.
According to Sabine Eichinger, specialist in bleeding disorders at the University of Medicine of Vienna, the response of the immune system that causes clotting is “Extremely rare” and involves a series of unusual combinations. In addition, the expert assured that this type of reaction would occur in very few patients, and in the case of the nurse who died in Austria, it could have been caused by an immune pathology unknown until now.
The European Medicines Agency (EMA) reported on Thursday that the Anglo-Swedish drugmaker’s coronavirus vaccine was “safe and effective,” a statement of support from the European regulator after initial uncertainty. The World Health Organization too was against the withdrawal of AstraZeneca doses because they “continue to have great potential” to reduce COVID-19 infections and deaths.
Eichinger coincided with the conclusions of the WHO and the EMA: vaccination against the coronavirus is safe and very rare cases of thrombosis can be treated if they are detected in time.
The doctor concluded by recalling that while the typical symptoms after vaccination, such as headache, nausea or pain in the legs, do not go away after four or five days, or if others appear, it is important to see a doctor.
In the meantime, the European countries which had suspended the inoculation of the immunizer AstraZeneca have resumed its application. The health authorities of the continent they try to bring tranquility to the population and they point out that the coronavirus vaccine is effective and safe.
Source: EFE
.
[ad_2]
Source link